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ABSTRACT
LAUREN GRACE DAIGLE: Evaluation of the Prevalence and Treatment Trends of
Diabetic Peripheral Neuropathy among Patients with Diabetes in a Rural Population
(Under the direction of Dr. Matthew W. Strum)
Evidence for adherence to the American Diabetes Association’s (ADA) screening
and treatment guidelines for various health complications of diabetes in rural populations
is limited. The ADA recommends annual foot and eye exams and supports the use of the
Semmes-Weinstein monofilament (SWM) to detect signs of diabetic peripheral
neuropathy (DPN). This study evaluated the prevalence and treatment trends of DPN
among patients with diabetes in a rural population. Fifty-two individuals over the age of
18, with known Type 1 or Type 2 diabetes mellitus, were recruited to participate.
Participants were asked to respond to a 29-item, multiple choice and freeform question
survey about the monitoring and management of their diabetes. A monofilament exam
was then performed on each participant using a 10g SWM to detect signs of DPN. Six
locations on the foot were tested with the 10g SWM, and a pedal pulse was recorded. The
results of the 10g SWM exam were compared to the survey responses for each
corresponding participant. Survey responses indicated that 21.2% of participants had
been diagnosed with DPN. Although not statistically significant due to limited sample
size, 17.3% of participants were identified by the SWM exam to have DPN but were
currently undiagnosed by their physician. Furthermore, 12.0% of participants had not had
an eye exam in over a year, and 28.8% did not have regular foot exams. Participants
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whose physicians performed regular foot exams were 3.0 times as likely to have an eye
exam within the last year compared to participants whose physicians did not perform
regular foot exams, demonstrating a positive correlation between foot and eye exams.
The health consequences of undiagnosed sequelae of diabetes can be devastating. More
specific data related to diabetes management and prevention of disease complications
(via appropriate screening processes) in underserved areas is warranted; however, this
study suggests that rural populations need greater attention and targeted educational
programs to enhance the level of care.
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INTRODUCTION
Diabetes mellitus is defined as “a group of diseases that affect how your body
uses blood sugar”.1 Diabetes mellitus is traditionally divided into two different subtypes,
type 1 (T1DM) and type 2 (T2DM). T1DM, previously referred to as insulin-dependent
diabetes mellitus, is more commonly diagnosed in children and results from defected β
cells in the pancreas, preventing the body from making insulin.2,3 T2DM, or non-insulin
dependent diabetes mellitus, differs from T1DM in that it develops when the body
becomes resistant to insulin, and eventually, the production of insulin becomes
inadequate. T2DM accounts for 90-95% of all diagnosed cases of diabetes.4,5
Insulin is a hormone that is secreted into the bloodstream by the β cells in the
pancreas. Responsible for the uptake of glucose from the blood into cells, insulin lowers
the blood glucose concentration. However, in diabetes, blood glucose levels rise as a
result of either the lack of insulin (T1DM) or the body’s unresponsiveness to insulin,
known as insulin resistance (T2DM). In order for insulin to function, it must attach to,
and then stimulate, specific receptors on the surface of cells.6 This process allows insulin
receptor substrate to be moved to the plasma membrane. Glucose is subsequently
transported into the cell where activation of several intracellular metabolic processes
occurs.6
In T2DM, the ability to stimulate the insulin receptor substrate is impaired.6 As a
result, blood glucose levels rise, causing the β cells to produce more insulin in an attempt
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to increase the uptake of glucose into cells. High demand on the β cells to hypersecrete
insulin leads to β cell dysfunction and ultimately β cell death.6 In contrast, T1DM results
from an abnormal immune response against the pancreatic β cells or from defected β
cells causing little or no insulin to be produced. Consequently, the insulin necessary to
participate in the pathway of glucose uptake into cells is unavailable. As a result, both
T1DM and T2DM cause glucose to accumulate in the blood, often having damaging
effects on the body.3,6
The risk factors for T1DM include having a family history of T1DM, geography,
and age. Individuals with a parent or sibling with T1DM are at an increased risk of
developing the condition because they are more likely to possess specific genes
associated with diabetes. An increased distance from the equator puts individuals at a
higher risk for developing T1DM as well due to less exposure to ultraviolet light and
lower vitamin D levels.7 T1DM is most common between the ages of four and seven and
again between ten and fourteen years of age.8
On the other hand, the risk factors for T2DM are quite different. Risk factors
include body weight, abdominal fat distribution, physical inactivity, family history, race,
age, prediabetes, polycystic ovary syndrome, and gestational diabetes.3 The primary risk
factor for developing T2DM is being overweight.3 High levels of fatty tissue cause cells
to become more resistant to insulin, consequently increasing blood glucose levels.3 Fat
storage distribution also influences risks for T2DM as storing fat primarily in the
abdomen puts individuals at a greater risk than storing fat in the hips and thighs.3
Additionally, lack of physical activity increases the risk of T2DM. Physical activity uses
glucose for energy and makes cells more sensitive to the presence of insulin.3 Lack of

2

physical activity consequently decreases the body’s sensitivity to insulin and can cause
the elevated blood glucose levels indicative of diabetes. A family history of T2DM as
well as being male, African American, American Indian, or Asian-American puts
individuals at a higher risk for developing the condition due to the presence of certain
genetic factors.3 Unlike T1DM, the risk for developing T2DM increases with age,
especially after age 45.3 Another risk factor, prediabetes, is when the blood glucose levels
are abnormally high, but not high enough to be considered diabetes.3 Prediabetes is often
a sign that the body is progressing towards a diabetic state.3 Lastly, polycystic ovary
syndrome as well as gestational diabetes in women has been correlated with an increased
risk for developing diabetes.3
Diabetes is typically diagnosed through blood tests (See Figure 1).9,10 The normal
glucose levels for a non-diabetic are 80-120 mg/dL before meals, 160 mg/dL or less two
hours after meals, and 100 mg/dL to 140 mg/dL at bedtime.11 Each test has slightly
different criteria that must be met. An A1C test is a way to measure blood glucose levels
for the past 2 to 3 months without the need for the individual to fast.12 The Fasting
Plasma Glucose test checks fasting blood glucose levels after an individual has not
consumed food or drink for 8 hours prior to the test.12 The Oral Glucose Tolerance Test
checks blood glucose levels before and 2 hours after consumption of a sweet drink.12
Finally, the Random Plasma Glucose Test is a test done on the blood at any time of day
when diabetes symptoms are severe.12 Use of such blood tests can provide the
information necessary for a proper diagnosis of diabetes.
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FIGURE 1: Criteria for the Diagnosis of Diabetes. From Standards of Medical Care in
Diabetes—2016

Some common symptoms of diabetes include excessive thirst and hunger, fatigue,
blurry vision, slow healing bruises, weight loss, and pain or numbness in the hands and
feet.13 As the condition progresses, other organs may be affected and other symptoms
may occur.13
Diabetes is the seventh leading cause of death in the United States today. 5
Roughly 29.1 million Americans had diabetes in 2014, with 1.7 million new diagnoses.
5,14

There are 21.0 million diagnosed cases of diabetes and 8.1 million undiagnosed

cases. Diabetes affects various ethnicities differently.5 Diabetes is most prominent among
American Indians/Alaska Natives, non-Hispanic blacks, Asian Americans and Hispanics.

4

Roughly 16% of the American Indians/Alaska Natives population has diagnosed
diabetes, making it the ethnicity with the highest percentage of diagnosed diabetes.5 The
differences in genetic factors as well as lifestyles impact the prevalence of diabetes
among various ethnicities.5 More importantly, 86 million adult Americans have
prediabetes, and as many as 1 in 3 Americans are expected to have diabetes in 2050 if
trends continue.5,14
On a more local level, approximately 11.7% of adult Mississippians had a
diagnosis of diabetes in 2012.5 The Mississippi State Department of Health reported that,
in 2012, Mississippi ranked first in the nation for cases of diagnosed diabetes while
Louisiana ranked second.5,15 Statistics show that 11.5% of the adult population in
Louisiana had a diagnosis of diabetes in 2012.5 Diabetes is clearly a condition that holds
great prevalence throughout the U.S. and particularly in the Southeast. A significant
portion of the United States’ population is affected by diabetes, costing over $245 billion
per year in healthcare.5 In Mississippi, the estimated cost of diabetes is $1.7 billion per
year.15
Uncontrolled or long-term diabetes can lead to microvascular complications.
These include retinopathy, nephropathy, and neuropathy. The most prominent and
common health complication associated with diabetes is diabetic neuropathy. The
American Diabetes Association (ADA) defines diabetic neuropathy as “the presence of
symptoms and/or signs of peripheral nerve dysfunction in people with diabetes after
exclusion of other causes”.16 Excess blood glucose can injure the capillaries that provide
blood to nerves and interferes with the ability of nerves to transmit signals.17 There are
four main types of diabetic neuropathies: peripheral neuropathy, autonomic neuropathy,
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radiculoplexus neuropathy and mononeuropathy.17 The most common form is diabetic
peripheral neuropathy.17 Symptoms of diabetic peripheral neuropathy include tingling,
burning, pain, and loss of feeling that starts at the tips of the fingers and toes.16,17
Symptoms tend to be worse at night and are often lessened by movement, walking or
standing.16 However, problems balancing and walking are also commonly seen in
individuals with diabetic peripheral neuropathy.16 Diabetic peripheral neuropathy may
affect one or more nerves and over time can lead to the complete loss of feeling in entire
limbs.16,17 The nerve damage that often results from diabetes puts the feet at an increased
risk for foot complications.3 Minor cuts and blisters can become infected and amputations
of extremities may be necessary in severe cases.3 More serious foot problems such as
deformities and bone and joint pain can also result. Diabetic neuropathies affect as many
as 50% of patients with diabetes to some degree.18 Of these individuals with diabetic
peripheral neuropathy, there were 73,000 non-traumatic lower-limb amputations
performed in 2010.5,19,20
Because diabetic peripheral neuropathy has no known cure, treatment tends to
focus on managing symptoms and slowing the progression of the disease.17 Wearing
proper footwear, maintaining a healthy blood pressure, eating healthy, exercising,
avoiding alcohol and smoking, as well as keeping the blood glucose within a target range
can help to delay the progression of diabetic peripheral neuropathy.17 Diabetic peripheral
neuropathy and its complications were estimated to cost between 4.6 and 13.7 billion
dollars annually in the United States. In fact, up to 27% of the medical costs of diabetes
in the United States is attributed to diabetic peripheral neuropathy.21
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Due to the high potential for serious health problems caused by diabetic
peripheral neuropathy, the ADA recommends that diabetic patients receive a
comprehensive foot exam at least once per year.22 All patients should be screened for
diabetic peripheral neuropathy beginning at diagnosis of T2DM and 5 years after the
diagnosis of T1DM. Foot exams should check for various dermatologic conditions such
as skin color, thickness, dryness, and cracking.19,22 The presence of ulcers, blisters and
calluses should also be checked.22 In addition, a musculoskeletal assessment should be
performed to look for deformities such as claw toes, prominent metatarsal heads, and
charcot joints.19,22 Pedal pulses may also be checked in some instances. The presence of
any of these conditions should be noted, and the patient should be referred to a physician
if the results seem indicative of possible diabetic peripheral neuropathy.19 Patients with
insensate feet, ulcers, and foot deformities should be examined at every physician visit
rather than just once a year.10
One other common and accurate way to test for diabetic peripheral neuropathy is
through Semmes-Weinstein monofilaments (SWM). These are typically made of fine
nylon and designed “such that the amount of pressure on the plantar surface of the great
toe is a function of the instrument, and not of the examiner”.16 SWM are single-fiber
nylon threads, and each generates a buckling stress.16 Each monofilament “is marked
with a number that represents the decimal log of 10 times the force in milligrams ranging
from 1.65 (000.45 g) to 6.65 (447 g) of linear force.”16 To test for neuropathy, the
monofilament is gently placed perpendicularly on the surface of the foot until the
monofilament buckles.16 This action is repeated several times on various areas of the
foot: the 1st, 3rd, and 5th metatarsal heads, and the plantar surface of the distal hallux.16
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These four monofilament testing sites have been shown to identify 90% of patients with
an insensate site.24 To test for complete loss of protective sensation, a 10g SWM should
be used.16 Several studies have shown that use of the 10g SWM is highly predictive of
future ulcerations, and its efficacy in screening for sensory loss has been confirmed in
several studies.23 When conducting a monofilament test for neuropathy, the sensation of
pressure using the 10g SWM should first be demonstrated for the patient on a proximal
site such as the arm.23 The patient should close their eyes and respond with “yes” during
the test whenever they feel the monofilament being applied.23 If the patient does not feel
the monofilament after it buckles, then the test site is considered to be insensate.25
Diabetes affects millions of Americans and is associated with many health
complications that have various effects on the body. Diabetic peripheral neuropathy is
one of the more common diabetes-related health complications and can have detrimental
effects on an individual, so it is important that patients with diabetes receive foot exams
regularly. Performing a foot exam using a 10g SWM is an accurate and simple way to
test for possible diabetic peripheral neuropathy. Since many rural populations do not
have easy access to healthcare, these populations have been shown to often have
untreated health conditions. However, data showing how diabetes in particular is
monitored and managed in rural populations is limited. As a result, this study sought to
test a rural population of people in a local community pharmacy using a 10g SWM to
determine the prevalence of diabetic peripheral neuropathy as well as how often it goes
undiagnosed by physicians in a rural population. The study also aims to analyze whether
the treatment trends of diabetic peripheral neuropathy are correlated with those of
diabetic retinopathy, another common sequelae of diabetes. By determining whether a
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correlation exists, hopefully physicians can develop better treatment plans to improve
patient care. The results of the study showing the prevalence of diabetic peripheral
neuropathy will be shared with physicians to hopefully raise awareness for diabetic
peripheral neuropathy and to help combat the adverse health risks associated with the
condition.
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MATERIALS AND METHODS
This study, “Evaluation of the Prevalence and Treatment Trends of Diabetic
Peripheral Neuropathy among Patients with Diabetes in a Rural Population” was
reviewed by the Institutional Review Board (IRB) at the University of Mississippi and
approved. Patients of Prairieville Pharmacy, located in Prairieville, Louisiana were
recruited as subjects. The pharmacist at Prairieville Pharmacy asked patients taking
medications commonly used to treat diabetes if they would be willing to participate.
Patients over the age of 18, with known diabetes mellitus, were eligible to participate.
Each participant was given a randomized code to keep his or her anonymity. The
participant was asked to complete a survey on Qualtrics asking various questions about
how his or her diabetes is monitored and managed, as well as other questions to gauge the
participant’s knowledge about his or her diabetes. Then, the participant was asked to
remove his or her shoes and socks on both feet. The investigator wore latex gloves, and
used a new pair of latex gloves between each participant. The investigator performed a
monofilament exam on the participant using a 10g Semmes-Weinstein monofilament
(SWM). The 10g SWMs were purchased through Medical Monofilament. A new 10g
SWM was used for each participant. The investigator first demonstrated for each
participant how the 10g SWM would be used and how it felt by applying the 10g SWM
to the participant’s forearm. Then, six sites on each foot were tested: the first, third, and
fifth metatarsal heads; the plantar surface of the distal hallux and fifth phalanx; and the
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dorsum pedis. (See Figure 2: Semmes-Weinstein Monofilament Test). The investigator
touched the 10g SWM to the same six sites on each foot in random order by applying just
enough pressure to cause the 10g SWM to buckle. The six testing sites were chosen based
on literature evaluations of the most accurate testing sites for detecting diabetic peripheral
neuropathy. The participant was asked to close his or her eyes and to respond “yes” any
time he or she felt the 10g SWM on his or her foot. If a participant did not respond “yes”
when the monofilament was applied to a particular site, the test site was considered to be
insensate. The number of “yes” responses was recorded on the participant’s Qualtrics
survey. Next, the investigator checked for a bilateral pedal pulse in each participant. The
bilateral pedal pulse was recorded as either “present” or “absent” for each participant.
The pedal pulse must have been detected on both feet in order to be considered present.
The presence or absence of the bilateral pedal pulse was recorded on the participant’s
Qualtrics survey. At the end of each participant’s time, a total of twelve sites were
evaluated with the 10g SWM. Each participant was offered a copy of the results from his
or her monofilament exam to take to his or her physician. The investigator discarded the
10g SWM and latex gloves into the proper trash receptacle.
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FIGURE 2: Semmes-Weinstein Monofilament Test. From American Medical
Association—2005
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OBSERVATIONS
Throughout the study, various observations were noted. Roughly the same
number of sensate test sites was observed on each foot, suggesting that the degree of
feeling on each foot was approximately equal for most participants. The dorsum pedis
was the site most commonly felt by participants. The first, third, and fifth metatarsal
heads as well as the plantar surface of the distal hallux and fifth phalanx were distributed
fairly equally in terms of how often participants responded “yes” to feeling the 10g
SWM. Participants with structural deformities in the bones of their feet had more
insensate test sites than participants without structural deformities in their feet. Also,
there was a general trend that participants with thick, callused skin on their feet had more
insensate test sites compared to participants without calluses. In addition, participants
who reported having physicians that provided regular foot exams tended to behave more
confidently about how they would perform on the monofilament exam compared to
participants whose physicians rarely performed foot examinations.
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RESULTS
Prevalence of Diabetic Peripheral Neuropathy in a Rural Population as Detected by
10g Semmes-Weinstein Monofilament Exam
Using the software, SPSS, the data collected were transferred from the Qualtrics
survey software to an SPSS document. To determine the prevalence of diabetic peripheral
neuropathy in the sample of participants, the results of the 10g SWM were analyzed with
SPSS. The number of “yes” responses to the monofilament exam was counted for each
participant. Participants were considered to test negative for diabetic peripheral
neuropathy if they had 10 or more “yes” responses. In other words, if the participant felt
9 or less of the 12 testing sites on the foot, he or she was classified as having diabetic
peripheral neuropathy. Descriptive statistics were used to determine the frequency of
participants who felt 9 or less of the testing sites using the 10g SWM. It was found that
15 of the 52 participants, or 28.8%, of the participants tested positive for diabetic
peripheral neuropathy using the 10g SWM.
Next, the results of the survey question in which participants were asked
to report whether or not they had ever been diagnosed with diabetic peripheral
neuropathy were analyzed. Participants who answered that they were unsure if they had
ever been diagnosed with diabetic peripheral neuropathy were classified as not having a
diagnosis of diabetic peripheral neuropathy. The results showed that 11 of the
participants, or 21.2%, reported a previous or current diagnosis of diabetic peripheral
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neuropathy. (See Figure 3: Proportion of Participants Reporting a Diagnosis of Diabetic
Peripheral Neuropathy)
Then, a cross-tabulation was done to compare the survey responses with the
results of the 10g SWM exam. The cross-tabulation identified 9 participants, or 17.3%,
who tested positive for diabetic peripheral neuropathy from the 10g SWM exam that
reported never being diagnosed with diabetic peripheral neuropathy in their survey
responses. Additionally, 5 participants, or 9.62%, reported a previous or current diagnosis
of diabetic peripheral neuropathy but tested negative for diabetic peripheral neuropathy
based on their results of the 10g SWM exam. A McNemar test was used to compare the
proportion of participants who reported a previous diagnosis of diabetic peripheral
neuropathy to those who tested positive for diabetic peripheral neuropathy from the 10g
SWM exam. A p-value of 0.424 was determined using a binomial distribution and a twotailed analysis, and thus concluded to be insignificant since p>0.05.
Therefore, it can be concluded that there was no statistically significant difference
between the proportion of participants who reported having a previous diagnosis of
diabetic peripheral neuropathy and the proportion of participants who tested positive for
diabetic peripheral neuropathy based on their results from the 10g SWM exam. (See
Figure 4: Comparison of Diagnosis of Diabetic Peripheral Neuropathy by Physician and
Results of the 10g Semmes-Weinstein Monofilament Exam)
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FIGURE 3: Proportion of Participants Reporting a Diagnosis of Diabetic Peripheral
Neuropathy
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FIGURE 4: Comparison of Diagnosis of Diabetic Peripheral Neuropathy by Physician
and Results of the 10g Semmes-Weinstein Monofilament Exam
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Relationship between Frequency of Foot and Eye Exams Among Patients with
Diabetes in a Rural Population
The ADA recommends that patients with diabetes receive a comprehensive foot
and eye exam at least once per year, and more often if the patient is at an increased risk
for, or has been diagnosed with diabetic peripheral neuropathy or diabetic retinopathy. To
evaluate adherence to the ADA’s recommendations for patients with diabetes having an
annual eye exam, data were collected through the Qualtrics survey software regarding the
last time participants received an eye exam. Through SPSS, survey responses were
grouped into having an eye exam “within the last year,” “over a year ago,” or
“unknown.” Descriptive statistics were done that showed that 11.5% of participants had
not had an eye exam in over a year, and 3.8%, or 2 participants, were not sure of how
long it had been since their last eye exam.
Next, to analyze adherence to the ADA’s recommendation that patients with
diabetes have an annual foot exam, data were collected through the Qualtrics survey
software regarding whether or not the physician managing the participant’s diabetes
performs regular examinations of the participant’s feet. Participants were first asked
whether or not their physician performs regular examinations of their feet to check for
bone deformities, slow healing wounds, and loss of feeling. Then, participants were asked
how frequently their doctor performed such foot exams. Survey responses were
categorized through SPSS into either “yes, participant has foot exam at least once
annually” or “no, participant does not receive annual foot exam.” The results showed that
71.2% of participants receive an annual foot exam, and 28.8% of participants do not
receive an annual foot exam.

18

Then, to determine whether there was a relationship between how frequently
participants received foot and eye exams, a cross-tabulation was performed using the
categories of survey responses mentioned above. An odds ratio was calculated to be 3.0,
meaning that participants whose physicians performed regular foot exams were 3.0 times
as likely to have an annual eye exam compared to participants whose physicians did not
perform regular foot exams. By running a Pearson chi-square test, a two-sided p-value of
0.20 was obtained, and thus insignificant because the p-value was greater than 0.05.
It can be concluded that there was no statistically significant relationship between
the frequency of having foot and eye exams. However, because there was a general trend
that participants who receive annual foot exams are more likely to have an annual eye
exam, the results may be significant from a clinical perspective. (See Figure 5:
Comparison of the Proportion of Participants who had an Eye Exam within the Last Year
Given that their Physician Performs Regular Foot Examinations)

Effect of Attending Diabetes Self-Management Class on Adherence to ADA’s
Recommendations for Foot and Eye Exams
To determine whether or not attending diabetes self-management class affects
adherence to the ADA’s guidelines for foot and eye exams, the proportion of participants
who have attended diabetes self-management class was first determined. A survey
question was developed through Qualtrics in which participants were asked whether they
had ever attended a diabetes self-management class. The results were analyzed using
SPSS to show that 38.5% of participants had never attended a diabetes self-management
class, while 61.5% of participants had attended a diabetes self-management class.
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FIGURE 5: Comparison of the Proportion of Participants who had an Eye Exam within
the Last Year Given that their Physician Performs Regular Foot Examinations
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Next, a cross-tabulation was performed to determine whether attending a diabetes
self-management class impacted adherence to the ADA’s eye exam guidelines. Two
participants were excluded from this analysis because they were unsure of the timing of
their last eye exam. Out of the 31 participants included who had attended a selfmanagement class, 90.3% had an eye exam within the last year. Out of the 19 participants
who had not attended a self-management class, 84.2% had an eye exam within the last
year. A Fisher’s Exact Test was performed, and a two-sided p-value of 0.661 was
obtained. Since p>0.05, the results were not statistically significant.
Then, another cross-tabulation was done to evaluate whether attending a diabetes
self-management class impacted adherence to the ADA’s foot exam guidelines. Out of
the 32 participants who had attended a self-management class, 78.1% reported having
regular foot exams performed by their physician. Of the 20 participants who had never
attended a self-management class, 60.0% reported having regular foot exams performed
by their physician. A Fisher’s Exact Test was done, and a p-value of 0.213 was obtained
using a two-tailed analysis. Therefore, the results were not statistically significant since p
was greater than 0.05. Although the effect of attending a diabetes self-management class
was not statistically significant, there is a general trend that participants who attended a
self-management class were more adherent to the ADA’s recommendations for foot and
eye exams.
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DISCUSSION
Regularly testing for and monitoring the common health complications of
diabetes mellitus plays a vital role in patient health care. Nearly half of all patients with
diabetes are affected by diabetic neuropathies, a condition that can be deadly and
debilitating without proper management. Ensuring that all patients with diabetes receive
the proper care for such health complications as outlined by the American Diabetes
Association is necessary and important. This is especially true in populations that have
limited access to or education about diabetes management, such as in a rural setting. This
study aimed to evaluate the prevalence of two of the common health complications of
diabetes and to determine how well these conditions were being tested for and monitored
in a rural population. By asking participants to provide information about their diabetes
management and then checking their feet for neuropathy with the monofilament test, the
investigator was able to compare their current understanding of their health with the
results from a reliable test for diabetic peripheral neuropathy. Almost one-third of all
participants showed signs of diabetic peripheral neuropathy through the monofilament
test. With such a high percentage of participants affected, these results confirm the
importance of testing for diabetic neuropathies. More importantly, over half of all
participants identified by the 10g SWM to have diabetic peripheral neuropathy were
undiagnosed by the physician managing their diabetes. Although not statistically
significant, these results are of clinical significance since they provide evidence that a
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considerable number of patients with diabetes in this rural population are not receiving
proper care for these serious health conditions. With a larger sample size, the results
could become statistically significant as well.
This study also analyzed whether there is a relationship between how frequently
patients with diabetes have foot and eye exams. Knowing if there is a relationship can be
helpful so that physicians may understand whether improving one area of patient care
may have similar effects on other areas of patient care as well. The investigator first
identified that over a quarter of all participants did not receive annual foot exams, and
roughly 15% did not have annual eye exams. These results indicate that while the
majority of patients with diabetes in this particular rural population were adherent to the
ADA’s recommendations for foot and eye exams, improvements are still necessary. More
specific data related to diabetes management and prevention of disease complications in
underserved areas is warranted; however, this study suggests that rural populations need
greater attention and targeted educational programs to enhance the level of care.
The results also showed that participants who receive annual foot exams were
three times as likely to have annual eye exams. Although these results were not
statistically significant due to a limited sample size, the results hold some degree of
clinical significance. Understanding the relationship between the management of health
complications of diabetes is important. The results suggest that improvements in one area
of patient care may positively affect other areas of patient care. This is especially helpful
in rural populations where access to health care is often more limited. Encouraging
adherence to one aspect of the ADA’s guidelines for managing the complications of
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diabetes can increase adherence to other aspects as well, leading to an overall
improvement in patient health outcomes.
Another aspect of diabetes care analyzed by this study was whether attending a
diabetes self-management class improved patient adherence to receiving annual foot and
eye exams. The results showed that only about sixty percent of participants had ever
attended a self-management class. Since such a low percentage of participants have
received proper education about managing their diabetes, improvements in patient
education in this rural populations are needed. Education about proper management of
diabetes is crucial so that patients may understand what signs and symptoms to watch for
and how to prevent some of the debilitating sequelae of diabetes.
Although the results were not statistically significant, it was found that there was
a roughly six percent increase in the number of participants who had annual eye exams in
the participants who had attended a diabetes self-management class compared to
participants who had not attended a self-management class. Additionally, there was about
a twenty percent increase in the number of participants who had annual foot exams in
participants who had attended a self-management class compared to those who had not
attended a self-management class. If a larger sample size had been used, these results
could have been statistically significant. Regardless, these results certainly appear to
possess significance clinically since there was an observed general trend that participants
who have proper education about how to manage their diabetes have improved adherence
to the ADA’s guidelines for foot and eye exams. Understanding that education improves
patient self-management provides support that educating patients and providing them
with educational opportunities is valuable and can lead to improved health outcomes.
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Proper management of diabetes includes more than just maintaining blood
glucose levels. Patients with diabetes should be aware of the effects of diabetes on
several other body systems. Patients and physicians should work together to ensure that
patients are properly educated about the importance of having annual foot and eye exams.
Furthermore, physicians should understand the importance of regularly examining their
patients for potential complications of diabetes. Patients in rural populations are often at
an increased risk for health complications due to limited access to health care facilities
and fewer educational opportunities. Although greater patient care may be needed across
all populations, it can be concluded from this study that patients in rural populations may
be in need of additional improvements in patient care. In the rural population included in
this study, there were a considerable number of patients who did not have regular foot
and eye exams and who had undiagnosed diabetic peripheral neuropathy. The results
verify the need for continued work toward greater diabetes care and provide insight into
the value of diabetes self-management education.
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Appendix A: Patient Survey
We will be looking at patients with diabetes. We want to see how many people have lost
some feeling in their feet and how often they have their feet looked at by a doctor. To
find this out, we want you to answer some questions that deal with your medical history
in regards to diabetes, diabetes complications, and foot-care. Your name will not be
recorded for any reason. The only information recorded will be whether you are male or
female, your age, and your ethnicity. You may skip any questions that you do not feel
comfortable answering. If you start the study and decide that you do not want to finish,
you may stop at any time. Whether or not you choose to participate or to withdraw will
not affect you in any way. Thank you in advance for your time!
1. Have you ever been diagnosed with diabetes?
a. Yes
b. No
2. If yes, what type of diabetes were you diagnosed with?
a. Type 1
b. Type 2
c. Gestational
d. I don’t know
3. How many years have you been diagnosed with diabetes?
________________________
4. Does your physician perform regular examinations of your feet to check for
bone deformities or slow-healing wounds?
a. Yes
b. No
5. Have you ever had a monofilament exam?
a. Yes
b. No
c. Not sure
6. If yes, about how many times have you had a monofilament exam? (skip to
question 7 if you answered “no” to question 5)
a. One time
b. A few times
c. Once a year
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d. More than once a year
7. Have you ever been diagnosed with peripheral neuropathy?
a. Yes
b. No
c. Not sure
8. If so, at what age were you first diagnosed with peripheral neuropathy?
_________________________
9. Do you check your feet regularly for blisters, ulcers, calluses, and ingrown
toenails?
a. Yes
b. No
10. How long does it typically take for your foot wounds to heal?
a. 2-4 days
b. About 1 week
c. About 2 weeks
d. Longer than 2 weeks
11. When was the last time you had an eye exam? __________________________________
12. Has your doctor ever made you pee in a cup?
a. Yes
b. No
13. Do you have microalbuminuria (protein in the urine)?
a. Yes
b. No
14. Do you currently take medication for diabetes management?
a. Yes
b. No
15. If yes, what type of diabetes medications do you take? Circle all that apply.
a. Oral (pill)
b. Injection
c. Insulin
16. Do you take insulin?
a. Yes
b. No
17. Do you take your medications as instructed?
a. Yes
b. No
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18. During the past 24 hours, how many different kinds of medication have you
taken (including diabetic and non-diabetic medications)?
______________________________________
19. If you have taken medication in the last 24 hours, how many of the
medications you have taken have been prescribed by your physician
(including diabetic and non-diabetic medications)?
_____________________________________
20. Have you ever attended diabetes self-management class?
a. Yes
b. No
21. What kind of physician do you see for your diabetes?
a. Primary care physician/family doctor
b. Endocrinologist
c. Other
22. Do you know your last A1C (hemoglobin A1C)
a. Yes
b. No
23. If so, what was your last A1C (hemoglobin A1C)? ______________________
24. Do you smoke?
a. Yes
b. No
25. If so, about how many cigarettes do you smoke per day? _______________________
26. How many years have you smoked? ___________________________
27. Age category:
a. 18-25
b. 26-30
c. 31-35
d. 36-40
e. 41-45
f. 46-50
g. 51-55
h. 56-60
i. 61-65
j. 66-70
k. 71-75
l. 76-80
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m. 81+
28. Gender
a. Male
b. Female
29. Ethnicity:
a. Caucasian
b. African American/Black
c. Hispanic/Latino
d. Pacific Islander
e. Native American/Alaskan
f. Asian
g. Other
Thank you for your participation!
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Appendix B: Monofilament Exam Form
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Appendix C: Patient Consent Letter
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